.Atea Pharmaceuticals' antiviral has actually fallen short an additional COVID-19 trial, yet the bio...
.Neurocrine Biosciences' mental illness course pivot has actually stopped working. The biotech was u...
.Sanofi has actually brought in a late access to the radioligand gathering, paying 100 million euros...
.After F2G's very first attempt to acquire a brand-new class of antifungal to market was actually th...
.Moderna has actually pledged to reduce R&D spending through $1.1 billion through 2027. The choic...
.Only four months after Sanofi wager $80 million in beforehand cash on Fulcrum Therapies' losmapimod...
.Cancer company Oncternal Therapeutics is folding all its own professional trials as well as giving ...
.Roche is actually keeping out hopes that its injectable excessive weight prospect can at some point...
.Novo Nordisk has actually lifted the top on a phase 1 trial of its oral amylin as well as GLP-1 rec...
.Merely a handful of brief weeks after succeeding an FDA Fast lane tag for its investigational BTK d...